Literature DB >> 24138417

QSAR analysis and molecular docking simulation of suggested peptidomimetic NS3 protease inhibitors.

Hamdy I A Mostafa, Nihal S El-bialy, Ahmed A Ezat, Noha A Saleh, Medhat A Ibrahim1.   

Abstract

Based on the N-terminal hexapeptide product of hydrolysis (EDVVCC) at HCV NS5A/5B junction, three modified groups of compounds are built. The first group contains linear peptides while the second and third groups contain P1-P3 and P2-P4 macrocyclic structures, respectively. Quantitative Structure Activity Relationship (QSAR) characterization and docking simulations are performed in order to investigate the potential of these compounds as HCV NS3/4A protease inhibitors. Based on the QSAR properties, the three most stable compounds due to their lowest total energy are P1-P3 and P2-P4 macrocycles of azahexapeptide sequence (DDIVP vinyl amino cyclopropane) and P2-P4 macrocycle of azahexapeptide sequence (DDIVP norvaline). They also have high surface area, solvent accessible surface area, volume, molar refractivity and polarizabilty. They have moderately low dipole moment and good log P values, as well. The docking scores of the best two P2-P4 macrocycles are just acceptable. The two compounds 5A/5B hexapeptide sequence (DDIVP vinyl amino cyclopropane) and P2-P4 macrocycle of azapentapeptide sequence (DIVP vinyl amino cyclopropane) yielded the best docking scores.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24138417     DOI: 10.2174/15734099113096660048

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  3 in total

1.  Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V).

Authors:  Ahmed A Ezat; Nihal S El-Bialy; Hamdy I A Mostafa; Medhat A Ibrahim
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

2.  In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Nigella sativa and Pimpinella anisum as Potential Inhibitors of 3CL Protease of SARS-CoV-2.

Authors:  Awatif A Hendi; Promy Virk; Manal A Awad; Mai Elobeid; Khalid M O Ortashi; Meznah M Alanazi; Fatemah H Alkallas; Maha Mohammad Almoneef; Mohammed Aly Abdou
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

3.  IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study.

Authors:  Abdo A Elfiky; Wael M Elshemey
Journal:  Med Chem Res       Date:  2016-03-04       Impact factor: 1.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.